Cargando…
Clinical characteristics and survival analysis in critical and non-critical patients with COVID-19 in Wuhan, China: a single-center retrospective case control study
Since the outbreak of COVID-19 in China at the end of 2019, the world has experienced a large-scale epidemic caused by the SARS-CoV-2. The epidemiological and clinical course of COVID-19 patients has been reported, but there have been few analyses about the characteristics, predictive risk factors,...
Autores principales: | Tian, Ran, Wu, Wei, Wang, Chunyao, Pang, Haiyu, Zhang, Zhiyu, Xu, Haopeng, Luo, Qingfeng, Gao, Peng, Shi, Jihua, Li, Wenbin, Qian, Hao, Guo, Fan, Li, Taisheng, Liu, Zhengyin, Wang, Jinglan, Zhou, Xiang, Qin, Yan, Yan, Xiaowei, Zhang, Shuyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567789/ https://www.ncbi.nlm.nih.gov/pubmed/33067568 http://dx.doi.org/10.1038/s41598-020-74465-3 |
Ejemplares similares
-
Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19
por: Ma, Jie, et al.
Publicado: (2020) -
Myocardial Injury on Admission as a Risk in Critically Ill COVID-19 Patients: A Retrospective in-ICU Study
por: Qian, Hao, et al.
Publicado: (2021) -
Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19)
por: Gao, Peng, et al.
Publicado: (2021) -
Absorbing filter AN69 surface treatment in critically ill COVID-19 patients: a single-center experience
por: Chen, Gang, et al.
Publicado: (2021) -
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
por: Zhang, Wen, et al.
Publicado: (2020)